IL-15 is also a key factor in the development, proliferation, and activation of NK cells and CD8+ T cells (Berger et al., 2019; Do Thi et al., 2019; Fiore et al., 2020; Liu et al., 2021), which are able to destroy cancer cells in the tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.